The Manufacturers Life Insurance Company Acquires Shares of 289,666 Ventas, Inc. $VTR

The Manufacturers Life Insurance Company acquired a new stake in Ventas, Inc. (NYSE:VTR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 289,666 shares of the real estate investment trust’s stock, valued at approximately $25,722,000.

Several other institutional investors have also modified their holdings of VTR. NewEdge Advisors LLC grew its stake in shares of Ventas by 856.1% during the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after purchasing an additional 7,097 shares in the last quarter. Empowered Funds LLC increased its holdings in Ventas by 6.8% in the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after buying an additional 536 shares during the last quarter. Woodline Partners LP raised its stake in Ventas by 46.8% in the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after buying an additional 11,739 shares in the last quarter. Focus Partners Wealth raised its stake in Ventas by 130.4% in the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after buying an additional 12,233 shares in the last quarter. Finally, Gamco Investors INC. ET AL purchased a new stake in Ventas during the 2nd quarter worth about $805,000. 94.18% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Ventas news, Director Michael J. Embler acquired 2,500 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The stock was acquired at an average cost of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.53% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on VTR. Mizuho upped their price objective on Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. KeyCorp boosted their target price on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Royal Bank Of Canada upped their price target on Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a report on Friday, August 14th. Wells Fargo & Company increased their price target on shares of Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Finally, The Goldman Sachs Group restated a “buy” rating and set a $110.00 price objective on shares of Ventas in a research report on Tuesday, May 19th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Ventas presently has an average rating of “Moderate Buy” and a consensus target price of $98.00.

Ventas Stock Down 0.6%

Shares of Ventas stock opened at $92.89 on Friday. Ventas, Inc. has a one year low of $66.38 and a one year high of $101.60. The company has a market cap of $47.65 billion, a P/E ratio of 172.02, a PEG ratio of 2.15 and a beta of 0.69. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. The firm has a fifty day moving average of $92.22 and a two-hundred day moving average of $87.54.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.01. The firm had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%.Ventas’s quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.87 earnings per share. On average, analysts forecast that Ventas, Inc. will post 3.89 earnings per share for the current year.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.